| 胡晓鹏,张 哲,晏昱婧,罗智勇,吴亚群.CAFs外泌体通过上调ABCB5诱导乳腺癌细胞化疗耐药[J].现代生物医学进展英文版,2018,(19):3637-3641. |
| CAFs外泌体通过上调ABCB5诱导乳腺癌细胞化疗耐药 |
| CAFs-exosomes Induce Chemoresistance of Breast Cancer Cells via Upregulating ABCB5 |
| Received:May 28, 2018 Revised:June 23, 2018 |
| DOI：10.13241/j.cnki.pmb.2018.19.008 |
| 中文关键词: 乳腺癌 肿瘤相关成纤维细胞 外泌体 耐药 |
| 英文关键词: Breast cancer Carcinoma-associated fibroblasts Exosomes Drug resistance |
| 基金项目:国家自然科学基金青年基金项目（81502373） |
|
| Hits: 476 |
| Download times: 243 |
| 中文摘要: |
| 摘要 目的：探讨肿瘤相关成纤维细胞（CAFs）诱导乳腺癌细胞耐药及其作用机制。方法：从临床样本中分离培养CAFs，获取条件培养基，并纯化外泌体。使用CAFs条件培养基或CAFs外泌体与CD44+的乳腺癌干细胞（CSCs）和CD44-的非干细胞亚群共培养，并用5氟尿嘧啶（5-FU）处理共培养的细胞，通过成球实验和CCK8实验检测细胞的自我更新能力和存活能力。抑制细胞中ABCB5的表达，检测5-FU对细胞存活能力的影响。结果：CAFs条件培养或外泌体处理的CSCs自我更新能力和对5-FU的耐药能力更强，成球能力和对5-FU耐药性上升约1.5-2倍。CAFs外泌体可提高CSCs中ABCB5的表达水平约4-5倍，抑制ABCB5可降低CSCs的耐药性至原来的约60-80%。结论：CAFs通过旁分泌外泌体增强CSCs的自我更新能力并通过上调CSCs中ABCB5的表达水平促进其对化疗药物的抵抗。 |
| 英文摘要: |
| ABSTRACT Objective: To explore drug resistance and its underlying mechanisms of breast cancer cells induced by carcinoma-as- sociated fibroblasts (CAFs). Methods: CAFs were isolated from clinical samples and cultured to produce conditioned medium (CM) fol- lowed by purification of exosomes. Sphere-formation assay and CCK8 assay were performed to detect the capacity of self-renewing and survival of CD44+ breast cancer stem cells (CSCs) and CD44- non-CSCs cocultured with CAFs-CM or exosomes and treated with 5-FU. The survival ability of CSCs was detected after knocking down of ABCB5. Results: Treatment with CAFs-CM or exosomes enhanced the capacity of self-renewing and resistance to 5-FU of CSCs, sphere formation ability and chemoresistance to 5-FU increased about 1.5 to 2 folds. CAFs-exosomes increased the expression of ABCB5 of CSCs to about 4 to 5 folds and knockdown of ABCB5 decreased its drug resistance to 60-80% of that of normal ABCB5 expression groups. Conclusion: CAFs-exosomes enhanced the capacity of self-renewing of CSCs and upregulated the expression of ABCB5 thus contributing to its resistance to chemotherapy. |
|
View Full Text
View/Add Comment Download reader |
| Close |
